Varicose Vein Treatment Market Research Report
Straits Research has released a new report titled Varicose Vein Treatment by Product type, application, Geographic trends, and Distribution Channel: Industry Opportunity and Analysis. The Varicose Vein Treatment Market report provides an in-depth analysis of key growth strategies, drivers, opportunities, key segments, Porter’s Five Forces analysis, and the competitive landscape.
The global varicose vein treatment market was valued at $ 376.64 million in 2017, and is projected to reach $ 589.06 million by 2025, growing at a CAGR of 5.7% from 2019 to 2026.
The Industry research report gives a plan for the future that will help companies and other stakeholders make good decisions that will bring good returns for many years. The report provides a practical overview of the global market and its real-time changes so that readers can make decisions about well-informed market projects. This report is specifically about the ways the market can grow and expand its operations in existing markets.
Request Free Sample Copy of Report @ https://straitsresearch.com/report/varicose-vein-treatment-market/request-sample
Some of the Top companies Influencing the Varicose Vein Treatment Market includes:
Key players in the global market for varicose vein treatment include Medtronic, AngioDynamics, Syneron Candela, BTG International Ltd., VVT Medical, F Care System, WON TECH Co., Ltd., DJO Global, Inc., Miravas, Mylan N.V., Teleflex Incorporated, Biolitec AG ,BSN medical, and SIGVARIS. The market for global varicose vein treatment is highly fragmented in nature, with different market players operating in local regions. Some of the key players are engaging in acquisitions, collaborations, and partnerships to gain a competitive edge. For instance, in 2019, Boston Scientific acquired BTG International Ltd to sell the devices used in minimally invasive procedures aimed at vascular diseases, such as varicose veins. In 2018, BTG International Ltd. acquired Novate Medical Ltd to strengthen its role in the vascular market. In March 2016, AngioDynamics partnered with Merz North America to market Asclera in the U.S. for varicose vein treatment. In 2006 it also acquired ‘Sotradecol’ from Bioniche Pharma Group for the same. In November 2017, Biolitec AG announced the results of the long-term study on LEONARDO Mini laser therapy to treat varicose veins to be a success.
Varicose Vein Treatment Market Overview | Impact of COVID-19
Finally, we are all aware of the ongoing COVID-19 pandemic, which is still affecting the growth of various regions around the world. The immediate impacts of the epidemic, on the other hand, are determined by what people want. People may quit buying products in some areas, but others may remain unchanged, with the potential for growth.
Quantifiable Data:
- Market segmentation by Type and Application / End-User
- By Type, Endovenous Ablation , Sclerotherapy , Ligation , Supportive Treatments By Product, Ablation Devices , Radio Frequency Ablation or Thermal Ablation , Laser Ablation Devices , Ultrasound Ablation Devices , Catheters or Kits for Sclerotherapy & Adhesion Injections , Compression Devices , Others By End Users, Academic Institutes and Centers , Hospitals and Clinics , Military Organizations
- Varicose Vein Treatment -Specific Applications Sales and Growth Rates (Historical & Forecast)
- Varicose Vein Treatment Industry sales, revenue, and growth rate during Forecast
- Varicose Vein Treatment size and growth rate, segmentation like application and type (Past and Forecast)
- Sales revenue, volume, and Y-O-Y growth rate (base year) of Varicose Vein Treatment industry.
The report forecasts revenue growth at all geographic levels and provides an in-depth analysis of the latest industry trends and development patterns in each of the segments and sub-segments. Some of the major geographies included in the market are given below:
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy)
- Asia Pacific (China, India, Japan, Singapore, Malaysia)
- Latin America (Brazil, Mexico)
- Middle East & Africa
This Free Report Sample Contains:
- A detailed introduction to the in-depth research report.
- Graphical summary of regional overview and analysis.
- Top producers in sales and revenue analysis.
- Special illustrations of ideas, restrictions, drivers and trends.
- Example pages from the report.
Buy Now: https://straitsresearch.com/buy-now/varicose-vein-treatment-market/global/
Trending Report:
https://www.openpr.com/news/2538575/global-food-biotechnology-market-growth-is-constantly-rising
https://www.openpr.com/news/2545562/at-6-5-of-cagr-modular-bridges-market-2022-size-will-rise
https://www.openpr.com/news/2545875/heat-pump-market-2022-along-with-covid-19-impact-analysis
About Us:
StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.
Contact Us:
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
Website: https://straitsresearch.com/
According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Get 10% Free Customization on this report @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22524107The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis.This report broadly segments the varicose vein treatment market into mode of treatment and products.
The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products.
The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.
On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.Browse and in-depth TOC on “Varicose Vein Treatment Market”67 - Tables19 - Figures149 - PagesRequest Bundle Reports @https://www.marketsandmarkets.com/RequestBundleReport.asp?id=22524107Objectives of the study are:• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders• To strategically profile the key players and comprehensively analyze their market sharesFor Press release, visit:https://www.marketsandmarkets.com/PressReleases/varicose-vein-treatment.aspStakeholdersVaricose vein treatment product manufacturers, vendors, and distributorsResearch institutes and government organizationsVenture capitalists and other government funding organizationsResearch and consulting firmsHealthcare institutions (hospitals and medical schools)Pharmaceutical and biotechnology companies
According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.
Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.
Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.
Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.
Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.
According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.
